ACTIVE_NOT_RECRUITING

The Influence of Race and MitoQ Supplementation on Skin Blood Flow in the Cold

Conditions

Cold Exposure Skin blood flow Skin temperature Oxidative stress Vasoconstriction Cold stress Racial disparities Reactive oxygen species Mitochondrial antioxidant Mitoquinone Mitoquinol Manual dexterity Peripheral cold injury

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Individuals who operate in cold weather are at risk of developing cold injuries, for example, frostbite. They also often experience a loss of hand function and joint mobility due to a decrease in skin temperature and blood flow. In addition, the risk of getting a cold injury is higher in the Black population compared to other racial and ethnic groups. Increases in oxidant compounds can cause the blood vessels in the skin to narrow and decrease skin temperature in the cold. However, it is unknown whether the higher risk of cold injury in Black individuals is because of a greater amount of oxidant compounds in the blood vessels. The purpose of this research is to see if an antioxidant supplement called MitoQ can help to improve skin temperature and blood flow in the cold and if the improvement is greater in Black individuals.

Official Title

The Influence of Race and MitoQ Supplementation on Skin Perfusion in the Cold

Quick Facts

Study Start:2024-09-16

Study Completion:2026-01

Study Type:Not specified

Phase:Not Applicable

Enrollment:Not specified

Status:ACTIVE_NOT_RECRUITING

Study ID

NCT06784531

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 40 Years

Sexes Eligible for Study:ALL

Accepts Healthy Volunteers:Yes

Standard Ages:ADULT

Inclusion Criteria	Exclusion Criteria
* Male or female, age 18-40 * In good health as determined by OMSO (Office of Medical Support and Oversight) * Willing to refrain from exercise and caffeinated or alcoholic beverages for 12 hours before each testing session * Willing to refrain from antioxidant-rich foods, such as blueberries, pecans, and dark chocolate, 48 h before each testing session * Eumenorrheic females (menstrual cycle length between 24-35 days) or females taking oral contraceptives, or utilizing implantable contraception (e.g., intrauterine device) * Have supervisor approval if active-duty military or a federal employee at NSSC	* History of cold injuries of any severity (e.g., frostbite, trench foot, chilblains) * Raynaud's syndrome * Cold-induced asthma/bronchospasm * Previous hand/finger injuries that impair dexterity and hand function * Metal hardware (plates/screws) in the forearms and hands * Smoke, vape, or use smokeless tobacco or other nicotine-containing products habitually (unless have quit \> 4 months prior) * Current use of medications (except for birth control) or dietary supplements that could alter cardiovascular, thermoregulatory, or vascular control (e.g., anti-hypertensives, statins) * History of disease of the gastrointestinal tract including (but not limited to) diverticulosis, diverticulitis and inflammatory bowel disease, peptic ulcer disease, Crohn's disease, ulcerative colitis; or previous gastrointestinal surgery * Have a history of renal disease including (but not limited to) chronic kidney disease, acute kidney injury, kidney stone disease, glomerular disease, or nephritis * Known allergies to medical adhesives * Known allergy to MitoQ * Difficulty swallowing pills * Heart, lung, kidney, muscle, or nerve disorder(s) * A planned MRI during the study or within 3 days after completing a cold test * Women who are pregnant, planning to become pregnant, or breastfeeding * Not willing to have small areas of skin on the body shaved (if deemed necessary for attachment of study instrumentation) * Have donated blood within 8 weeks of the study or plan to donate blood during the study * Lesions on a significant portion of the upper extremities due to skin pigmentation disorders (e.g., vitiligo, psoriasis)

Inclusion Criteria

Exclusion Criteria

* Male or female, age 18-40
* In good health as determined by OMSO (Office of Medical Support and Oversight)
* Willing to refrain from exercise and caffeinated or alcoholic beverages for 12 hours before each testing session
* Willing to refrain from antioxidant-rich foods, such as blueberries, pecans, and dark chocolate, 48 h before each testing session
* Eumenorrheic females (menstrual cycle length between 24-35 days) or females taking oral contraceptives, or utilizing implantable contraception (e.g., intrauterine device)
* Have supervisor approval if active-duty military or a federal employee at NSSC

* History of cold injuries of any severity (e.g., frostbite, trench foot, chilblains)
* Raynaud's syndrome
* Cold-induced asthma/bronchospasm
* Previous hand/finger injuries that impair dexterity and hand function
* Metal hardware (plates/screws) in the forearms and hands
* Smoke, vape, or use smokeless tobacco or other nicotine-containing products habitually (unless have quit \> 4 months prior)
* Current use of medications (except for birth control) or dietary supplements that could alter cardiovascular, thermoregulatory, or vascular control (e.g., anti-hypertensives, statins)
* History of disease of the gastrointestinal tract including (but not limited to) diverticulosis, diverticulitis and inflammatory bowel disease, peptic ulcer disease, Crohn's disease, ulcerative colitis; or previous gastrointestinal surgery
* Have a history of renal disease including (but not limited to) chronic kidney disease, acute kidney injury, kidney stone disease, glomerular disease, or nephritis
* Known allergies to medical adhesives
* Known allergy to MitoQ
* Difficulty swallowing pills
* Heart, lung, kidney, muscle, or nerve disorder(s)
* A planned MRI during the study or within 3 days after completing a cold test
* Women who are pregnant, planning to become pregnant, or breastfeeding
* Not willing to have small areas of skin on the body shaved (if deemed necessary for attachment of study instrumentation)
* Have donated blood within 8 weeks of the study or plan to donate blood during the study
* Lesions on a significant portion of the upper extremities due to skin pigmentation disorders (e.g., vitiligo, psoriasis)

Contacts and Locations

Study Locations (Sites)

U.S. Army Research Institute of Environmental Medicine

Natick, Massachusetts, 01760

United States

Collaborators and Investigators

Sponsor: United States Army Research Institute of Environmental Medicine

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-09-16

Study Completion Date2026-01

Study Record Updates

Study Start Date2024-09-16

Study Completion Date2026-01

Terms related to this study

Keywords Provided by Researchers

Skin blood flow
Skin temperature
Oxidative stress
Vasoconstriction
Cold stress
Racial disparities
Reactive oxygen species
Mitochondrial antioxidant
Mitoquinone
Mitoquinol
Manual dexterity
Peripheral cold injury

Additional Relevant MeSH Terms

Cold Exposure